Pharmaceutical

Syros Pharmaceuticals gets grant for CDK7 inhibitors for treating cancer and other diseases

Discover how Syros Pharmaceuticals' patented compounds inhibit CDK7, inducing cellular apoptosis and treating diseases like cancer and ALS.

Jun 12, 2024 - 04:00
Syros Pharmaceuticals gets grant for CDK7 inhibitors for treating cancer and other diseases
Discover how Syros Pharmaceuticals' patented compounds inhibit CDK7, inducing cellular apoptosis and treating diseases like cancer and ALS.
Read the original article

Tags:

Previous Article

Silence Therapeutics gets grant for compound for rna interference therapy in tre...

Next Article

United Laboratories International gets grant for method for removing contaminant...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Emergency medicine is grappling with a surprising problem: The prospect of too many physicians

Emergency medicine is grappling with a surprising probl...

Oct 28, 2023

FDA accepts Astellas’ sNDA for CRESEMBA to treat fungal infections

FDA accepts Astellas’ sNDA for CRESEMBA to treat fungal...

Aug 12, 2023

Biotheryx and Incyte sign agreement to develop protein degraders for oncology

Biotheryx and Incyte sign agreement to develop protein ...

Apr 6, 2023